1. Home
  2. HUDI vs JSPR Comparison

HUDI vs JSPR Comparison

Compare HUDI & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huadi International Group Co. Ltd.

HUDI

Huadi International Group Co. Ltd.

N/A

Current Price

$0.90

Market Cap

17.2M

Sector

Industrials

ML Signal

N/A

JSPR

Jasper Therapeutics Inc.

HOLD

Current Price

$0.47

Market Cap

14.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUDI
JSPR
Founded
1998
2018
Country
China
United States
Employees
N/A
22
Industry
Steel/Iron Ore
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.2M
14.9M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
HUDI
JSPR
Price
$0.90
$0.47
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$15.50
AVG Volume (30 Days)
431.2K
705.5K
Earning Date
01-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.75
$0.42
52 Week High
$5.46
$7.19

Technical Indicators

Market Signals
Indicator
HUDI
JSPR
Relative Strength Index (RSI) 38.75 34.19
Support Level $0.75 $0.42
Resistance Level $1.35 $1.02
Average True Range (ATR) 0.14 0.07
MACD 0.01 0.01
Stochastic Oscillator 15.76 25.07

Price Performance

Historical Comparison
HUDI
JSPR

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Share on Social Networks: